DSCSA: Ready or Not ...here it comes! - On Demand

The Drug Supply Chain Security Act (DSCSA) outlines requirements for enhanced drug distribution security, which include the steps to achieve interoperable, electronic tracing of products at the package level.  The requirements for enhanced drug distribution security go into effect on November 27, 2023.  As we end the 10-year roll out of this new legislation, authorized trading partners are preparing for compliance without full interpretation of the guidelines.  This webinar will provide an overview of the new regulations as well as address ongoing concerns regarding data exchange, interoperability, and communication between regulators and trading partners.

Target Audience

  • Pharmacists
  • Pharmacy Technicians
  • Other Healthcare Professionals

Learning Objectives

  • Outline dispenser requirements for DSCSA
  • Describe the role of GLNs for tracking and tracing
  • Identify the primary goal of NABP’s DSCSA Interoperability Network
  • Outline the verification process at the package level
  • Describe how to validate licensure of authorized trading partners
Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
  • 1.00 General CE - Attendance
Course opens: 
04/12/2023
Course expires: 
04/11/2024
Planning Committee
 
Gretchen Brummel, PharmD, BCPS (Course Director)    
Consulting Solutions Director
 
Jackie Stokes, BS    
Manager, Pharmacy Program
 
Faculty
 
Carolyn Liptak, MBA, BS, PharmD
Pharmacy Executive IV
Vizient Inc
                       
Josh Bolin
Associate Executive Director, Federal Affairs and Strategy
NAPB 
 
Randy Braun, PharmD
Coordinator, Informatics and Automation, UNC Supply Chain Pharmacy               
University of North Carolina
             
Justin Macy, PharmD, JD   
Digital Health Senior Manager                      
NAPB 
 
 

Disclosure

As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.
 
Ineligible companies – those companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
 
It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.
 
FDA Off-Label Use
 
Faculty presenters are also expected to disclose any discussion of (1) off-label or investigational uses of FDA approved commercial products or devices or (2) products or devices not yet approved in the United States.
 
Disclosure Statements
 
Absence of Relevant Financial Relationships
 
None of the planners, faculty, or others in a position to control content for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
 

Disclaimer

The education provided through this activity is for continuing education purposes only. The views and opinions expressed in this activity are those of the faculty/presenters and do not necessarily reflect the views of Vizient, Inc.

Joint Accreditation Statement

In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
 
 

Designation Statement(s) 

Pharmacists (CPE)

Vizient, Inc. designates this live activity for a maximum of 1.00 contact hours for Pharmacists. 

Universal Activity Number: JA0006103-0000-23-047-H03-P

Pharmacy Technicians (CPE)

Vizient, Inc. designates this enduring material for a maximum of 1.00 contact hours for pharmacy technicians. 

Universal Activity Number: JA0006103-0000-23-047-H03-T

Other Healthcare Professionals (General CE Credit)

Vizient, Inc. will award all other healthcare professionals who successfully complete the activity a Certificate of Participation.  Various state license boards and credentialing bodies accept certificates of participation from accredited CE activities to meet CE requirements for license renewals and re-certification. It is the responsibility of the participant to contact their state licensing board and/or certifying body for verification on credit eligibility reciprocity.

 

Available Credit

  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
  • 1.00 General CE - Attendance
Please login or register to take this course.

 

Select the Obtain Credit button to access the activity evaluation and to claim CE Credit.